METAVAX®-Platform

ARTES attends BioEurope 2019

ARTES and Burnet Institute publish data on production and immunogenicity of malaria transmission-blocking vaccine candidates

ARTES Biotech­nol­o­gy and Bur­net Insti­tute recent­ly pub­lished data on the effi­cient pro­duc­tion of malar­ia vac­cine can­di­dates using virus-like par­ti­cles (VLP) pre­sent­ing malar­ia tran­s­mis­­sion-stage anti­gens, which were capa­ble of induc­ing tran­s­mis­­sion-block­­ing anti­bod­ies.